Nicola Miller Selected Research

Nicola Miller Research Topics

Disease

49	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2007
41	Neoplasms (Cancer) 01/2022 - 11/2007
7	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 04/2010
3	Carcinogenesis 01/2022 - 09/2010
3	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 06/2011
3	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 08/2008
2	Disease Progression 01/2022 - 01/2009
2	Triple Negative Breast Neoplasms 06/2014 - 04/2011
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Ductal Carcinoma 10/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016
1	Genetic Risk Score 05/2015
1	Familial Breast Cancer 02/2015
1	Hypersensitivity (Allergy) 12/2013
1	Colonic Neoplasms (Colon Cancer) 12/2013
1	Rectal Neoplasms (Rectal Cancer) 02/2013
1	Esophageal Neoplasms (Esophageal Cancer) 11/2009
1	Hepatoblastoma 08/2008
1	Neuroblastoma 08/2008

Drug/Important Bio-Agent (IBA)

33	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2008
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
17	Estrogen ReceptorsIBA 12/2017 - 08/2009
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
7	Hormones (Hormone)IBA 10/2021 - 08/2009
6	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 01/2009
4	Phenobarbital (Luminal)FDA Link 07/2020 - 01/2009
4	Biological ProductsIBA 01/2019 - 04/2011
4	3' Untranslated Regions (3' UTR)IBA 01/2016 - 01/2014
4	Estrogens (Estrogen)FDA Link 01/2015 - 01/2008
3	Epidermal Growth Factor (EGF)IBA 01/2022 - 10/2021
3	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
3	Genetic Markers (Genetic Marker)IBA 05/2015 - 04/2011
3	ErbB-2 ReceptorIBA 01/2014 - 01/2009
3	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 10/2010
2	Circulating MicroRNAIBA 07/2020 - 07/2015
2	LuciferasesIBA 06/2014 - 04/2013
2	Messenger RNA (mRNA)IBA 07/2013 - 04/2011
2	RNA (Ribonucleic Acid)IBA 01/2013 - 11/2009
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2011 - 06/2011
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 06/2011 - 08/2008
1	Cell-Free Nucleic AcidsIBA 01/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2015
1	ChromatinIBA 01/2015
1	Estrone FDA Link 05/2014
1	GlucuronidesIBA 05/2014
1	Cytochrome P-450 CYP3AIBA 05/2014
1	Deoxyribonucleases (DNase)FDA Link 12/2013
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2013
1	Complement System Proteins (Complement)IBA 06/2013
1	Cyclin D1IBA 04/2013
1	Formaldehyde (Formol)FDA Link 02/2013
1	ParaffinIBA 02/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2011
1	P-2 (P 2)IBA 02/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2009
1	Progesterone FDA LinkGeneric 01/2009
1	Estrogen Receptor alphaIBA 01/2008

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2009
6	Neoadjuvant Therapy 01/2022 - 11/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
1	Radiotherapy 10/2021
1	Perioperative Period 03/2010
1	Chemoradiotherapy 11/2009